Abstract: According to the recent studies, malicious software (malware) is increasing at an alarming rate, and some malware can hide in the system by using different obfuscation techniques. In order ...
Investing.com - TD Cowen initiated coverage on Vor Biopharma, Inc. (NASDAQ:VOR) with a Buy rating on Wednesday, citing the potential of the company’s telitacicept therapy. The stock, currently trading ...
In recent months, Vor Biopharma closed a US$424.83 million shelf registration, repriced employee stock options, and reported positive late-stage clinical data for its autoimmune drug candidate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback